Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001831:Body Temperature; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D006454:Hemoglobins / Q000097:blood; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D006965:Hyperplasia / Q000601:surgery; D007275:Injections, Intravenous; D008297:Male; D010919:Placebos; D011183:Postoperative Complications / Q000188:drug therapy*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000601:surgery
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D006454:Hemoglobins; D010919:Placebos